Trial · NCT00866359
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Phase (Days 1 to 85) | STARTED | Placebo (Oral) BID | 56 | |
| Treatment Phase (Days 1 to 85) | STARTED | Apremilast 30mg (Oral) BID | 55 | |
| Treatment Phase (Days 1 to 85) | STARTED | Placebo/Apremilast 30 mg | 0 | |
| Treatment Phase (Days 1 to 85) | STARTED | Apremilast 30mg/Apremilast 30mg | 0 | |
| Treatment Phase (Days 1 to 85) | COMPLETED | Placebo (Oral) BID | 45 | |
| Treatment Phase (Days 1 to 85) | COMPLETED | Apremilast 30mg (Oral) BID | 50 | |
| Treatment Phase (Days 1 to 85) | COMPLETED | Placebo/Apremilast 30 mg | 0 | |
| Treatment Phase (Days 1 to 85) | COMPLETED | Apremilast 30mg/Apremilast 30mg | 0 | |
| Treatment Phase (Days 1 to 85) | NOT COMPLETED | Placebo (Oral) BID | 11 | |
| Treatment Phase (Days 1 to 85) | NOT COMPLETED | Apremilast 30mg (Oral) BID | 5 | |
| Treatment Phase (Days 1 to 85) | NOT COMPLETED | Placebo/Apremilast 30 mg | 0 | |
| Treatment Phase (Days 1 to 85) | NOT COMPLETED | Apremilast 30mg/Apremilast 30mg | 0 | |
| Extension Phase (Day 86 to 169) | STARTED | Placebo (Oral) BID | 0 | |
| Extension Phase (Day 86 to 169) | STARTED | Apremilast 30mg (Oral) BID | 0 | |
| Extension Phase (Day 86 to 169) | STARTED | Placebo/Apremilast 30 mg | 45 | |
| Extension Phase (Day 86 to 169) | STARTED | Apremilast 30mg/Apremilast 30mg | 50 | |
| Extension Phase (Day 86 to 169) | COMPLETED | Placebo (Oral) BID | 0 | |
| Extension Phase (Day 86 to 169) | COMPLETED | Apremilast 30mg (Oral) BID | 0 | |
| Extension Phase (Day 86 to 169) | COMPLETED | Placebo/Apremilast 30 mg | 44 | |
| Extension Phase (Day 86 to 169) | COMPLETED | Apremilast 30mg/Apremilast 30mg | 47 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00866359/flow